These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 354517)

  • 21. In vitro antifungal activities of Bay n 7133 and Bay L 9139, two new orally absorbed antifungal imidazole derivatives, against pathogenic yeasts.
    Fromtling RA; Yu HP; Shadomy S
    Mycopathologia; 1984 Apr; 86(1):45-50. PubMed ID: 6330557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antifungal susceptibility of clinically isolated Candida albicans by broth microdilution method].
    Yamazumi T; Kuroda T; Ohata T; Obana Y; Furuta I
    Kansenshogaku Zasshi; 1998 Aug; 72(8):813-9. PubMed ID: 9780584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antifungal activity of sertaconazole.
    Drouhet E; Dupont B
    Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
    Lamfon H; Porter SR; McCullough M; Pratten J
    J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of culture media on the antifungal activity of miconazole and amphotericin B methyl ester.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Oct; 134(4):336-41. PubMed ID: 789787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Action of miconazole at high concentrations against Candida albicans.
    D'Auria FD; Villa A; Simonetti N
    J Chemother; 1989 Jul; 1(4 Suppl):240-2. PubMed ID: 16312385
    [No Abstract]   [Full Text] [Related]  

  • 28. Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole.
    De Nollin S; Borgers M
    Antimicrob Agents Chemother; 1975 May; 7(5):704-11. PubMed ID: 1096812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal activity of two tissue conditioners combined with nystatin, miconazole and fluconazole against Candida albicans.
    Chopde N; Pharande A; Khade MN; Khadtare YR; Shah SS; Apratim A
    J Contemp Dent Pract; 2012 Sep; 13(5):695-8. PubMed ID: 23250177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ; Espinel-Ingroff A; Shadomy S
    Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action mechanism of antifungal imidazole derivatives clotrimazole and miconazole: lipid specificity and binding sites].
    Yamaguchi H; Iwata K
    Nihon Saikingaku Zasshi; 1975 Jan; 30(1):261. PubMed ID: 765566
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative activities of miconazole and the anticancer drug tamoxifen against Candida albicans.
    Beggs WH
    J Antimicrob Chemother; 1994 Jul; 34(1):186-7. PubMed ID: 7961210
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
    Marriott MS
    J Gen Microbiol; 1980 Mar; 117(1):253-5. PubMed ID: 6993625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic interaction of miconazole and fluconazole at sub-MIC level on Candida albicans.
    Mikami Y; Takahashi A; Yazawa K; Terao K; Ueno Y
    Mycoses; 1992; 35(11-12):321-7. PubMed ID: 1302808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azole susceptibility and hyphal formation in a cytochrome P-450-deficient mutant of Candida albicans.
    Lees ND; Broughton MC; Sanglard D; Bard M
    Antimicrob Agents Chemother; 1990 May; 34(5):831-6. PubMed ID: 2193620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repeated exposure of Candida spp. to miconazole demonstrates no development of resistance.
    Ghannoum MA; Herbert J; Isham N
    Mycoses; 2011 Jul; 54(4):e175-7. PubMed ID: 20236241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
    Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole.
    Borgers M; De Brabander M; Van Den Bossche H; Van Cutsem J
    Postgrad Med J; 1979 Sep; 55(647):687-91. PubMed ID: 392485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect.
    Kobayashi D; Kondo K; Uehara N; Otokozawa S; Tsuji N; Yagihashi A; Watanabe N
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3113-7. PubMed ID: 12234832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fungicidal activity of tioconazole in relation to growth phase of Candida albicans and Candida parapsilosis.
    Beggs WH
    Antimicrob Agents Chemother; 1984 Nov; 26(5):699-701. PubMed ID: 6097174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.